Publications by authors named "J D Zbinden"
Implant Mismatch does not Affect Patient Outcomes in Primary Reverse Shoulder Arthroplasty.
J Shoulder Elbow Surg
December 2024
Background: There is a paucity of literature on manufacturer mismatch in reverse shoulder arthroplasty (RSA). It is unclear if use of different implant manufacturers for the glenoid side and the humeral side influences patient outcomes in primary RSA. We hypothesize that patients undergoing primary RSA with manufacturer mismatch such that humeral and glenoid components are from different manufacturers will not experience adverse outcomes when compared to a cohort of patients with humeral and glenoid components from the same manufacturer.
View Article and Find Full Text PDFScapular spine fractures following reverse shoulder arthroplasty have been associated with complications that include nonunion and fixation failure. This Technical Note presents a surgical approach for enhancing the stability and strength of spine fracture osteosynthesis. The method involves the utilization of double plating in conjunction with fibular allograft reinforcement anchored in the supraspinous fossa to provide support under the acromion.
View Article and Find Full Text PDFArticle Synopsis
- The TRILUMINATE Pivotal trial investigated the impact of tricuspid regurgitation (TR) on end-organ function and the effectiveness of transcatheter edge-to-edge repair (TEER) compared to medical therapy alone in patients with severe TR.
- The study included 572 patients who were split into TEER and control groups, examining how changes in end-organ function correlate with hospitalizations for heart failure (HF) and mortality over 12 months.
- Results showed that while TEER did not significantly differ from medical therapy alone in overall end-organ function improvements, successful TEER did lead to enhanced function in specific patient subgroups, indicating potential benefits in targeted treatment.
Background: There is a common concern that range of motion (ROM) is negatively affected by the Latarjet procedure. We hypothesize that the Latarjet procedure results in full recovery of ROM postoperatively and significantly improved patient-reported outcome measures.
Methods: Patient data were prospectively collected from a randomized controlled trial to analyze outcomes after open Latarjet procedure.
Article Synopsis
- * The protein lysosomal trafficking regulator (LYST) is key to managing the transport and dynamics of these organelles, and mutations in the LYST gene lead to Chédiak-Higashi syndrome, which impacts immune function.
- * Despite being known for eight decades, LYST's exact role in cellular biology is still not fully understood, and ongoing research is exploring its implications in treatments for immune disorders, regenerative medicine, and cancer.